PharmaBiotech IP USA 2008 28-30 May, 2008 Ritz-Carlton Philadelphia, PA Protect Critical Patents and Drive Sustainable Growth Through IP-Driven Business Strategies

Intellectual property is more than defending inventions, it is business critical. With potential reforms and recent Supreme Court and Federal circuit rulings, protecting and enforcing intellectual property is becoming increasingly complex and critical to profitability. PharmaBiotech IP brings together 37 leading IP practitioners to discuss strategies to enhance and ensure patent protection.

The event balances the challenges of IP protection, enforcement and management providing both strategic and actionable insights through case studies and interactive session formats.

• Amidst potential reforms and recent Supreme Court and Federal circuit rulings – how can you effectively navigate the waters and adapt your strategies to ensure long term protection and enforcement of your patents?
• With these changes in legislation, how can you adapt your prosecution and enforcement strategies to protect products coming on line, strategically manage your portfolio to get the best out of it and extend the useful life cycle of commercially valuable assets?
• As IP-driven business strategies are the key to future growth, how do you truly align IP with the business and overcome the perception that the IP function can be a resource and not a roadblock to become a true partner of the business?

At PharmaBiotech IP Learn To:

• Effectively navigate recent and potential regulatory changes to ensure long term protection and enforcement of your patents
• Enhance strategic management of your portfolio to get the best out of it
• Implement innovative ways to extend the useful life cycle of your most commercially valuable assets
• Meld IP and business strategies to become a true partner of the business and drive future growth

View The 37 IP Leaders Including:

	Li Westerlund Vice President, Global IP Bavarian Nordic
	Balaram Gupta Associate Vice President, U.S. Patent Operations Sanofi Aventis
	Lee Caffin Divisional Vice President Global IP Strategy Abbott Laboratories
	Scott Brown Vice Presidnet, General Counsel, Head of NIBR Patents Novartis Institute of Biomedical Research Novartis
	Robert Hrubiec Vice President Intellectual Property and Chief Patent Counsel Cephalon
	Mark E. Boulding Senior Vice President and General Counsel PTC Therapeutics

Don’t miss our separately bookable Patent Protection & Enforcement Masterclass.  This Masterclass will focus on key changes and how to adapt your prosecution strategies to enhance patent protection and ensure you can enforce it in the future.

Sponsored by: